<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.eubusiness.com/pharma/RSS">
  <title>Pharmaceuticals Policy in the EU</title>
  <link>http://www.eubusiness.com</link>
  
  <description>
    
       Latest business news about Pharmaceuticals and Medicines Policy in the European Union
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2007-01-02T13:22:44Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.eubusiness.com/logo.jpg"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1213288322.44"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1212412626.43"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1211187722.06"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Pharma/innovative-medicines.01"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1201871822.86"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1200487621.28"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Pharma/antitrust-pharma-guide"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1200480421.22"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Trade/essential-medicines"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Trade/wto-generic-medicines"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1195479121.44"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/news-eu/1195474624.88"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Pharma/emcdda-report.07"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Pharma/clinical-trials.01"/>
        
        
            <rdf:li rdf:resource="http://www.eubusiness.com/Pharma/consultation-eu.01"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.eubusiness.com/news-eu/1213288322.44">        <title>European regulators approve breast cancer drug: GSK</title>        <link>http://www.eubusiness.com/news-eu/1213288322.44</link>        <description>British pharmaceutical firm GlaxoSmithKline said on Thursday that European regulators had given marketing approval for its tablet breast cancer drug Tyverb.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                <dc:date>2008-06-12T17:44:07Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1212412626.43">        <title>EU targets Sanofi-Aventis over obstruction of anti-trust probe</title>        <link>http://www.eubusiness.com/news-eu/1212412626.43</link>        <description>The Commission has opened an investigation into whether French pharmaceutical group Sanofi-Aventis obstructed an inspection of its premises.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Headline3</dc:subject>                    <dc:subject>Competition</dc:subject>                <dc:date>2008-06-02T15:11:16Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1211187722.06">        <title>First EU licence granted for pre- pandemic bird flu vaccine</title>        <link>http://www.eubusiness.com/news-eu/1211187722.06</link>        <description>The European Commission has granted the first licence to market a vaccine in preparation for a pandemic of H5N1 bird flu in Europe.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Headline3</dc:subject>                    <dc:subject>Health</dc:subject>                <dc:date>2008-05-19T10:22:03Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Pharma/innovative-medicines.01">        <title>Innovative Medicines Initiative boost for Europe's pharmaceutical industry</title>        <link>http://www.eubusiness.com/Pharma/innovative-medicines.01</link>        <description>With the launch of its first call for proposals, the Innovative Medicines Initiative (IMI) got underway on 30 April. Joining forces, the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) hope to bring Europe back to the forefront of medical innovation.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                <dc:date>2008-05-05T23:00:27Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1201871822.86">        <title>European Commission targets Germany over pharmacy rules</title>        <link>http://www.eubusiness.com/news-eu/1201871822.86</link>        <description>The European Commission has initiated infringement proceedings against Germany over its restrictions on the ownership of pharmacies.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Headline1</dc:subject>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Competition</dc:subject>                <dc:date>2008-02-02T15:28:51Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1200487621.28">        <title>Top European pharma firms confirm EU antitrust probe</title>        <link>http://www.eubusiness.com/news-eu/1200487621.28</link>        <description>Anglo-Swedish drugs giant AstraZeneca and British peer GlaxoSmithKline said Wednesday they had been approached by EU regulators as part of an antitrust probe into the pharmaceutical sector.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Competition</dc:subject>                <dc:date>2008-01-16T14:09:45Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Pharma/antitrust-pharma-guide">        <title>Antitrust sector inquiry into pharmaceuticals - guide</title>        <link>http://www.eubusiness.com/Pharma/antitrust-pharma-guide</link>        <description>News, background information and web links about European Union policies on pharmaceuticals and medicines.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Headline2</dc:subject>                    <dc:subject>Competition</dc:subject>                <dc:date>2008-01-16T11:49:54Z</dc:date>        <dc:type>Guide</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1200480421.22">        <title>EU launches antitrust probe into pharmaceutical sector</title>        <link>http://www.eubusiness.com/news-eu/1200480421.22</link>        <description>The European Commission said Wednesday it had launched an antitrust probe into the pharmaceutical industry on concerns about uncompetitive behaviour in the sector.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2008 AFP. All other Copyright 2008 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Headline2</dc:subject>                    <dc:subject>Competition</dc:subject>                <dc:date>2008-01-17T17:41:25Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Trade/essential-medicines">        <title>Access to essential medicines</title>        <link>http://www.eubusiness.com/Trade/essential-medicines</link>        <description>Infectious diseases are responsible for almost half of all deaths in developing countries, and half of these diseases are caused by HIV (AIDS), tuberculosis and malaria. More than 2 billion inhabitants of the world do not have regular access to adequate treatment and cure. AIDS, tuberculosis and malaria alone kill 5 million people each year mostly in developing countries.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Trade</dc:subject>                <dc:date>2007-11-19T16:22:19Z</dc:date>        <dc:type>Link</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Trade/wto-generic-medicines">        <title>WTO deal on generic medicines - guide</title>        <link>http://www.eubusiness.com/Trade/wto-generic-medicines</link>        <description>News, background information and web links about the trade policy of the European Union.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Trade</dc:subject>                <dc:date>2007-11-19T16:17:21Z</dc:date>        <dc:type>Guide</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1195479121.44">        <title>EU adopts WTO deal on access to generic medicines</title>        <link>http://www.eubusiness.com/news-eu/1195479121.44</link>        <description>The EU on Monday adopted a WTO initiative to improve access for the world's poorest people to cheaper drugs against diseases such as HIV/AIDS and tuberculosis.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2007 AFP. All other Copyright 2007 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Headline2</dc:subject>                <dc:date>2007-11-19T16:27:17Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/news-eu/1195474624.88">        <title>Bayer announces billion-euro environmental investment</title>        <link>http://www.eubusiness.com/news-eu/1195474624.88</link>        <description>The German pharmaceutical and chemicals giant Bayer will invest one
billion euros (1.46 billion dollars) over three years in environmental
protection activities, it said Monday.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Text and Picture Copyright 2007 AFP. All other Copyright 2007 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.</dc:rights>                    <dc:subject>Environment</dc:subject>                    <dc:subject>Pharmaceuticals</dc:subject>                <dc:date>2007-11-19T13:58:15Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Pharma/emcdda-report.07">        <title>2007 Annual report from the EU drugs agency</title>        <link>http://www.eubusiness.com/Pharma/emcdda-report.07</link>        <description>Drug facts, figures and analyses: across Europe and by country - Latest trends and legal, political, social and health responses - Selected issues: Drugs and driving; drug use among the under 15s; cocaine</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Health</dc:subject>                <dc:date>2007-11-08T17:49:49Z</dc:date>        <dc:type>Link</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Pharma/clinical-trials.01">        <title>Biotech industries still see room for improvement in Clinical Trials Directive</title>        <link>http://www.eubusiness.com/Pharma/clinical-trials.01</link>        <description>The European Association for Bioindustries, EuropaBio, has repeated its call for the review of the EU's Clinical Trials Directive and its implementation into national laws.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub2</dc:creator>        <dc:rights>Copyright © European Communities, 2007. Neither the Commission of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&amp;D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host - http://cordis.europa.eu . Access to CORDIS is currently available free-of-charge.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Health</dc:subject>                <dc:date>2007-10-08T18:55:00Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.eubusiness.com/Pharma/consultation-eu.01">        <title>EU Commission launches consultation on pharmaceuticals</title>        <link>http://www.eubusiness.com/Pharma/consultation-eu.01</link>        <description>The European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>eub</dc:creator>        <dc:rights>Copyright © European Communities, 2007. Neither the Commission of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&amp;D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host - http://cordis.europa.eu . Access to CORDIS is currently available free-of-charge.</dc:rights>                    <dc:subject>Pharmaceuticals</dc:subject>                    <dc:subject>Research &amp; Technology</dc:subject>                <dc:date>2007-08-03T20:10:56Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>
